- Growing Science: A Decade Devoted to Advancing Cancer Research at the Sloan-Kettering Institute
A decade ago, the Sloan-Kettering Institute embarked on an effort to broaden and streamline its research activities. - Forging Alliances, Enhancing Understandings
Memorial Sloan-Kettering and The City College of New York Work have fostered a collaborations aimed at reducing cancer health disparities. - An Interview with Boris Bastian
Appointed Chair of the Department of Pathology at Memorial Sloan-Kettering in April 2010, Dr. Bastian leads pathologists and clinicians in finding new ways to integrate genetic information with traditional clinical observations to diagnose cancer and guide treatment. - New Nanotechnology Center Combines Cutting-Edge Science with Memorial Sloan-Kettering's Expertise in Patient Care
To take advantage of the growing field of nanotechnology, Memorial Sloan-Kettering has established a Nanotechnology Center. - New Targeted Therapy Shows Promise for Advanced Melanoma
A multicenter study led by Memorial Sloan-Kettering Cancer Center investigators concluded that treatment with a new targeted therapy called PLX4032 resulted in significant tumor shrinkage in 80 percent of patients with advanced melanoma. - Harmful Immune Reactions Might One Day Be Curbed with Cell-Based Therapy
A team of researchers led by Memorial Sloan-Kettering immunologist Alexander Rudensky has gained new understanding about regulatory T cells — a subtype of immune cells that suppresses the immune system’s reactivity. - Memorial Sloan-Kettering Researchers Are 2010 Rock Stars of Science
Three Memorial Sloan-Kettering Cancer Center investigators — including the Center’s new President, Craig B. Thompson — have been featured with singer-songwriter Debbie Harry to lead the Geoffrey Beene Gives Back® 2010 Rock Stars of Science™ campaign in GQ magazine’s December “Men of the Year” issue. - New Research Fund Targets Gastric Cancer
To spearhead ongoing progress against the stomach cancer, Memorial Sloan-Kettering has launched an ambitious program known as the James E. Gerstner Fund for Gastric Cancer Research. - Marc Ladanyi Named to Endowed Chair
Marc Ladanyi has been named the incumbent of the newly endowed William Ruane Chair in Molecular Oncology. - Zvi Fuks Elected to the Institute of Medicine
Zvi Fuks has been elected a member of the Institute of Medicine, one of the highest honors in the fields of health and medicine. - Joseph Deasy Named Chair of Medical Physics
Joseph O. Deasy has joined Memorial Sloan-Kettering as an attending physicist and Chair of the Department of Medical Physics. - Mahmoud B. El-Tamer Joins Memorial Sloan-Kettering as Member
Mahmoud B. El-Tamer is a breast surgeon who comes to Memorial Sloan-Kettering from NewYork-Presbyterian Hospital where he spent more than ten years as an attending surgeon at Columbia University Medical Center.
Inside MSKCC
|
©2013 Memorial Sloan-Kettering Cancer Center